These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 30217198)
1. Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties. Gu Y; Yang M; Tang X; Wang T; Yang D; Zhai G; Liu J J Nanobiotechnology; 2018 Sep; 16(1):68. PubMed ID: 30217198 [TBL] [Abstract][Full Text] [Related]
2. Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics. Yang M; Gu Y; Yang D; Tang X; Liu J J Nanobiotechnology; 2017 Dec; 15(1):88. PubMed ID: 29202753 [TBL] [Abstract][Full Text] [Related]
3. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis. Gu Y; Tang X; Yang M; Yang D; Liu J Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415 [TBL] [Abstract][Full Text] [Related]
4. Cubic and hexagonal liquid crystals as drug carriers for the transdermal delivery of triptolide. Shan QQ; Jiang XJ; Wang FY; Shu ZX; Gui SY Drug Deliv; 2019 Dec; 26(1):490-498. PubMed ID: 31081409 [TBL] [Abstract][Full Text] [Related]
5. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats. Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813 [TBL] [Abstract][Full Text] [Related]
6. Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment. Wu B; Lu ST; Zhang LJ; Zhuo RX; Xu HB; Huang SW Int J Nanomedicine; 2017; 12():1853-1862. PubMed ID: 28331310 [TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of triptolide-phospholipid complex to treat rheumatoid arthritis. Liu XY; Pei WJ; Wu YZ; Ren FL; Yang SY; Wang X Drug Deliv; 2021 Dec; 28(1):2127-2136. PubMed ID: 34617835 [TBL] [Abstract][Full Text] [Related]
8. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review. Garcês A; Amaral MH; Sousa Lobo JM; Silva AC Eur J Pharm Sci; 2018 Jan; 112():159-167. PubMed ID: 29183800 [TBL] [Abstract][Full Text] [Related]
9. SLN and NLC for topical, dermal, and transdermal drug delivery. Souto EB; Baldim I; Oliveira WP; Rao R; Yadav N; Gama FM; Mahant S Expert Opin Drug Deliv; 2020 Mar; 17(3):357-377. PubMed ID: 32064958 [No Abstract] [Full Text] [Related]
10. Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum. Guo T; Zhang Y; Zhao J; Zhu C; Feng N J Nanobiotechnology; 2015 Jul; 13():47. PubMed ID: 26156035 [TBL] [Abstract][Full Text] [Related]
11. Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis. Zhang L; Chang J; Zhao Y; Xu H; Wang T; Li Q; Xing L; Huang J; Wang Y; Liang Q Int J Nanomedicine; 2018; 13():2051-2064. PubMed ID: 29670349 [TBL] [Abstract][Full Text] [Related]
12. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487 [TBL] [Abstract][Full Text] [Related]
13. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Mei Z; Chen H; Weng T; Yang Y; Yang X Eur J Pharm Biopharm; 2003 Sep; 56(2):189-96. PubMed ID: 12957632 [TBL] [Abstract][Full Text] [Related]
14. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401 [TBL] [Abstract][Full Text] [Related]
15. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats. Zhang C; Peng F; Liu W; Wan J; Wan C; Xu H; Lam CW; Yang X Int J Nanomedicine; 2014; 9():1049-63. PubMed ID: 24591827 [TBL] [Abstract][Full Text] [Related]
16. Homotypic cell membrane-camouflaged biomimetic PLGA nanoparticle loading triptolide for the treatment of hepatocellular carcinoma. Li Z; Lan J; Wu Y; Ding Y; Zhang T Drug Deliv; 2024 Dec; 31(1):2354687. PubMed ID: 38823413 [TBL] [Abstract][Full Text] [Related]
17. Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery. Gönüllü Ü; Üner M; Yener G; Karaman EF; Aydoğmuş Z Acta Pharm; 2015 Mar; 65(1):1-13. PubMed ID: 25781700 [TBL] [Abstract][Full Text] [Related]
18. A study of microemulsion systems for transdermal delivery of triptolide. Chen H; Chang X; Weng T; Zhao X; Gao Z; Yang Y; Xu H; Yang X J Control Release; 2004 Aug; 98(3):427-36. PubMed ID: 15312998 [TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam. Khurana S; Bedi PM; Jain NK Chem Phys Lipids; 2013; 175-176():65-72. PubMed ID: 23994283 [TBL] [Abstract][Full Text] [Related]
20. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles. Andrade LM; de Fátima Reis C; Maione-Silva L; Anjos JL; Alonso A; Serpa RC; Marreto RN; Lima EM; Taveira SF Eur J Pharm Biopharm; 2014 Sep; 88(1):40-7. PubMed ID: 24816130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]